BridgeMD
New treatment option for Tracheostomy
Official title SV With TTPEE Measurement Predicts Upper Airway Patency in Prolonged Tracheostomy Patients
ClinicalTrials.gov ID: NCT07107243
What this study is testing
- What it's testing
- The aim of this study is to evaluate the feasibility of predicting upper airway patency in patients with prolonged tracheostomy using a non-invasive method combining speaking valve (SV) and transtracheal end-expiratory pressure (TTPEE) through a multicenter study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Weaned from ventilator more than 48 hours
- No any organ failure
- No sepsis
- Stable heart rate and blood pressure
- Lung infection under control
You likely can't join if
- Serious dysfunction of vital organs
- Inability to tolerate cuff deflation
- Laryngopharyngeal trauma
- Known severe upper airway obstruction before referrer to our department
- Endoscopy(bronchoscopy or laryngoscopy) has been performed and the condition of the upper airway has known
See the full eligibility criteria
- Weaned from ventilator more than 48 hours
- No any organ failure
- No sepsis
- Stable heart rate and blood pressure
- Lung infection under control
- PCO2\<60mmHg
- Patient and family sign informed consent form
- Serious dysfunction of vital organs
- Inability to tolerate cuff deflation
- Laryngopharyngeal trauma
- Known severe upper airway obstruction before referrer to our department
- Endoscopy(bronchoscopy or laryngoscopy) has been performed and the condition of the upper airway has known
The study team makes the final eligibility decision.
Where it's taking place
- Hunan, Hunan, China
- Guangxi, Jiangbin, China
- Beijing, Shijingshan, China
- Jilin City, Yanbian, China
- Henan, Zhengzhou, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hunan, Hunan, China; Guangxi, Jiangbin, China; Beijing, Shijingshan, China; Jilin City, Yanbian, China; Henan, Zhengzhou, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.